Načítá se...
Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics
Current subcutaneously (s.c.)-injected insulin (INS) products result in a hyperinsulin exposure to peripheral tissues (skeletal muscle and adipose) while INS hardly accesses to liver after injection. This unphysiological distribution raises risks of hypoglycemia episode and causes weight gain after...
Uloženo v:
| Vydáno v: | Tissue Barriers |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910833/ https://ncbi.nlm.nih.gov/pubmed/27358753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21688370.2016.1156804 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|